Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses

Garín, Olatz; Ferrer, Montse; Pont, Àngels; Rué, Montserrat; Kotzeva, Anna; Wiklund, Ingela; Ganse, Éric Van; Alonso, Jordi

doi:10.1007/s11136-008-9416-4

Cited by 165 publications

(148 citation statements)

References 101 publications

Supporting

Mentioning

140

Contrasting

Unclassified

Order By: Relevance

“…Quality of life assessed by means of the standard MLHF questionnaire remained at the same level for both modes and differences between the baseline and end of follow-up were not statistically signifi cant. This fact is surprising with respect to the signifi cant NYHA improvement mentioned above, since most of the MLHF questions are directly or indirectly related to physical functioning and correlate with the NYHA and 6-Minute Walk Test (6MWT) (26). Nevertheless, results of other studies concerning quality of life are very variable and do not always follow the above assumption.…”

Section: Discussionmentioning

confidence: 94%

TUGENDHAT: a pilot randomized study on effects of biventricular pacing in patients with bradycardia pacing indication and normal systolic function on heart failure, atrial fibrillation and quality of life (results of 12 month follow-up)

Táborský

Ríhová²,

Mráz³

et al. 2013

BLL

View full text Add to dashboard Cite

Abstract:Background: Since the late 1990s, a growing number of clinical studies have indicated that long-term permanent right ventricular (RV) apical pacing will induce severe complications such as development of heart failure, increased burden of atrial fi brillation leading to decreased quality of life. Aim of the study: To investigate whether cardiac resynchronization therapy (CRT) using biventricular (BiV) pacing can prevent the development of left ventricular (LV) dysfunction, LV remodelling, worsening of the clinical status and quality of life in chronically RV paced patients with normal LV ejection fraction (EF). Methods and results:A total of 127 patients with Class I indication for permanent cardiac pacing and without established indication for CRT were subjected to 6 months of RV and BiV pacing in a patient-blinded, randomized crossover trial. Treatment effects of BiV pacing were evaluated for LV function, LV remodelling and clinical status. Conclusion: BiV pacing, compared to RV pacing, did not change LV function and quality of life in patients with the absence of LV dysfunction or remodelling, standard bradycardia pacing indications in a pilot phase (12-month follow-up) of the TUGENDHAT trial. The fi nal report will be published after 60-month follow-up termination (Tab. 5, Fig. 3, Ref. 30). Full Text in PDF www.elis.sk. Key words: BiV and RV pacing, LV remodelling, heart failure, atrial fi brillation, quality of life. Results of several trials have supported the fact that right ventricular (RV) apical pacing might lead to adverse clinical outcomes in patients with standard pacing indications. Nevertheless, RV apical pacing continues to be practiced by many physicians because of its easy accessibility and relative stability over time (1, 2). The optimal mode and site of pacing remain undefi ned.The detrimental effect of RV pacing is probably most important in patients with pre-existing left ventricular (LV) dysfunction and may lead to worsening of heart failure (3, 4). In RV pacing, the sequence of electrical activation resembles the activation pattern in left bundle branch block (LBBB). This asynchronous electrical pattern is accompanied by abnormal dyssynchronous mechanical interactions within the LV (5). Experimental data suggested that biventricular (BiV) pacing might preserve myocardial performance better than RV apical pacing in patients with atrioventricular (AV) block and normal systolic function (6). The underlying mechanism may be a signifi cant reduction in LV systolic dyssynchrony, as shown by Cojoc et al (7). In the majority of patients with severe LV dysfunction and severe clinical heart failure associated with either LBBB-or RV pacing-induced dyssynchrony, BiV pacing improves clinical status, reduces mortality and morbidity, reduces heart failure (HF) hospitalizations, reverses LV remodelling and improves LV function (8, 9). Therefore, BiV pacing is nowadays recommended in patients with ventricular dyssynchrony (QRS > 120 ms), severe LV dysfunction [LV ejection fraction (LVEF) < 0.35] ...

show abstract

Section: Discussionmentioning

confidence: 94%

TUGENDHAT: a pilot randomized study on effects of biventricular pacing in patients with bradycardia pacing indication and normal systolic function on heart failure, atrial fibrillation and quality of life (results of 12 month follow-up)

Táborský

Ríhová²,

Mráz³

et al. 2013

BLL

View full text Add to dashboard Cite

show abstract

“…A systematic review with meta-analysis aiming to assess conceptual models and psychometric properties of five QoL assessment instruments for individuals with HF (MLHFQ, Chronic Heart Failure Questionnaire -CHFQ, Quality of Life Questionnaire for Severe Heart Failure -QLQ-SHF, KCCQ and Left Ventricular Dysfunction Questionnaire -LVD-36) showed that all had adequate psychometric properties, although there are concerns related to the construct validity of CHFQ and the response capacity of the QLQ-SHF (36) . Thus, QoL measurements used in studies included in this review can be considered reliable, since CHFQ and QLQ-SHF were not used by the authors.…”

Section: Discussionmentioning

confidence: 99%

“…Therefore, individualized education focused on disease self-management improves individuals' QoL (40) . This type of monitoring has good results due to low operational costs and easiness obtaining of information (36)(37)(38)(39)(40)(41) .…”

Section: Discussionmentioning

confidence: 99%

“…IG: Presence during hospitalization, with practical supervision of measurements of arterial pressure, heart frequency and symptoms, distribution of educational resources on self-monitoring; telephone monitoring, with a questionnaire on signs of worsening HF, other symptoms, medication, use of health services, mood and general health status and well-being; explanation and names of medication; necessary adjustments to specialized care administered by a nurse (n=352). Instrument: SF- 36 The program was coordinated by nurses and involved general physicians and cardiologists.…”

Section: Journal Of Cardiac Failurementioning

confidence: 99%

See 1 more Smart Citation

Intervenções não farmacológicas para melhor qualidade de vida na insuficiência cardíaca: revisão integrativa

et al. 2017

View full text Add to dashboard Cite

Nursing, Clinical and Surgical Nursing Department. São Paulo, Brazil. How to cite this article: Amaral DR, Rossi MB, Lopes CT, Lopes JL. Nonpharmacological interventions to improve quality of life in heart failure: an integrative review. Rev Bras Enferm [Internet]. 2017;70(1):187-98. DOI: http://dx.doi.org/10.1590/0034-7167-2016-0112Submission: 04-01-2016Approval: 09-07-2016 ABSTRACT Objective: to identify articles that assessed the effectiveness or effi cacy of nonpharmacological interventions to improve quality of life of people with heart failure in the literature. Method: an integrative literature review was performed in Lilacs, MedLine and SciELO databases, including randomized or nonrandomized clinical trials and quasi-experimental studies published between 2003 and 2014, in Portuguese, English or Spanish. Results: twenty-three studies were included. The categories of nonpharmacological interventions that improved quality of life of people with heart failure were: Remote health monitoring, Instructions on health practices, Physical activity follow-up and Traditional Chinese Medicine practices. Conclusion: these results can guide the selection of interventions to be implemented by health professionals that treat people with heart failure. Future systematic reviews with meta-analyses are needed in order to identify the most effective interventions for improving these individuals' quality of life. Descriptors: Clinical trials; Heart failure; Quality of Life; Review; Nursing. RESUMO Objetivo: identifi car, na literatura, artigos que avaliaram a efetividade ou efi cácia de intervenções não farmacológicas para melhorar a qualidade de vida de pessoas com insufi ciência cardíaca. Método: revisão integrativa de literatura realizada nas bases de dados Lilacs, MedLine e SciELO, incluindo ensaios clínicos randomizados ou não randomizados e estudos quaseexperimentais publicados entre 2003 e 2014, em português, inglês e espanhol. Resultados: foram incluídos 23 estudos. As categorias de intervenções não farmacológicas que melhoraram a qualidade de vida de pessoas com insufi ciência cardíaca foram: Monitoramento remoto da saúde, Orientação sobre práticas de saúde, Acompanhamento de atividade física e Práticas de Medicina Tradicional Chinesa. Conclusão: estes resultados podem direcionar a seleção de intervenções a serem implementadas por profi ssionais de saúde que cuidam de pessoas com insufi ciência cardíaca. Futuras revisões sistemáticas com metanálise são necessárias para identifi car as intervenções mais efi cazes para melhorar a qualidade de vida desses indivíduos. Descritores: Estudos de Intervenção; Insufi ciência Cardíaca; Qualidade de Vida; Revisão; Enfermagem. RESUMEN Objetivo: identifi car, en la literatura, artículos que evaluaron la efectividad o efi cacia de intervenciones no farmacológicas para mejorar la calidad de vida de personas con insufi ciencia cardíaca. Método: revisión integrativa de literatura realizada en las bases de datos Lilacs, MedLine y SciELO, incluyendo ensayos clínicos aleatorios o no...

show abstract

“…We constructed the score on the basis of the Minnesota Living with Heart Failure Questionnaire, which is one of the most widely used questionnaires to evaluate HF specific quality of life. 13,14) The score was calculated just before the administration of TLV and at 1 week after TLV treatment in all patients. The internal consistency among each item was sufficient (Cronbach's alpha, 0.766).…”

Section: Methodsmentioning

confidence: 99%

Tolvaptan Can Improve Clinical Course in Responders

et al. 2013

View full text Add to dashboard Cite

SummaryWe previously defi ned "responders" as patients with increases in urine volume (UV) on day 1 after the administration of tolvaptan (TLV), and demonstrated that responders to TLV could be predicted with considerable accuracy by urine osmolality (U-OSM) levels. Responders and non-responders to TLV should be associated with different clinical courses after a certain time following TLV administration. Therefore, the aim of the present study was to validate our defi nition of responders by clinical parameters 1 week after administration of TLV. Data (n = 85) were obtained from inhospital patients with decompensated heart failure (HF) who had received TLV at 3.75-15 mg daily, and clinical data at 1 week after the administration of TLV were compared with those of baseline. Sixty patients (70.6%) were "responders", in whom UV on day 1 increased after the administration of TLV compared with day 0. "Non-responders" were older, and had higher serum creatinine concentration and lower baseline U-OSM than "responders". Serum creatinine concentration increased signifi cantly in "non-responders", but was unchanged in "responders". Body weight, plasma B-type natriuretic peptide concentration, and HF symptom score decreased significantly in "responders", but remained unchanged in "non-responders". Increases in UV after the fi rst administration of TLV were closely correlated with improvement of congestive HF after 1 week of TLV treatment, which verifi ed our defi nition of "responders" to TLV. (Int Heart J 2013; 54: 377-381)

show abstract

Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses

Abstract: Most of the questionnaires studied met minimum psychometric criteria, though current evidence would primarily support the use of the MLHFQ, followed by the KCCQ and CHFQ.

Cited by 165 publications

References 101 publications

TUGENDHAT: a pilot randomized study on effects of biventricular pacing in patients with bradycardia pacing indication and normal systolic function on heart failure, atrial fibrillation and quality of life (results of 12 month follow-up)

TUGENDHAT: a pilot randomized study on effects of biventricular pacing in patients with bradycardia pacing indication and normal systolic function on heart failure, atrial fibrillation and quality of life (results of 12 month follow-up)

Intervenções não farmacológicas para melhor qualidade de vida na insuficiência cardíaca: revisão integrativa

Tolvaptan Can Improve Clinical Course in Responders

Contact Info

Product

Resources

About